360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Élan Corporation plc

Type: Company

Name: Élan Corporation plc (Elan Corporation Plc, Elan Corporation plc)

Nationality: Ireland

Fact Sheet: Fact Sheet for Elan Corporation, plc

First reported Jun 18 2013 - Updated 8 hours ago - 12 reports

Royalty pulls out so who will buy Elan?

Royalty Pharma has finally abandoned its $8 billion bid for Elan Corp, leaving observers to wonder who will make an offer for the Irish drugmaker which put itself up for sale last week.Royalty has withdrawn its appeal against a ruling by the Irish Takeover ... [Published Pharma Times - 8 hours ago]

Entities: Élan Corporation plc, Corey Davis, natalizumab, Regeneron

First reported 22 hours ago - Updated 18 hours ago - 4 reports

Biogen Idec Inc

Is Elan Corporation, plc (ADR) (ELN) Pushing Its Luck?

Recently Elan Corporation, plc (ADR) (NYSE:ELN)'s shareholders voted against management's proposal to invest $1 billion in Theravance Inc (NASDAQ:THRX), a deal which a fellow Fool calculates to be ill conceived. Shareholders also voted against the purchase ... [Published InsiderMonkey.com - 18 hours ago]

Entities: Élan Corporation plc, Tysabri, Biogen Idec Inc, New York Stock Exchange

First reported Jun 18 2013 - Updated 21 hours ago - 2 reports

Royalty Pharma drops bid for Elan Corp.

Alaric DeArmentRoyalty Pharma will not buy Irish drug maker Elan Corp., the company said Tuesday.read more ... [Published Drug Store News - 21 hours ago]

Entities: Élan Corporation plc, Royalty Pharma Management LLC, axillary

First reported Jun 18 2013 - Updated 22 hours ago - 4 reports

Pension Appointed Lead Plaintiff In Lawsuit Against SAC

The Alabama pension fund that brought a class-action lawsuit against SAC Capital Advisors for alleged insider-trading will serve as the lead plaintiff in another suit against the hedge fund, a judge has ruled.The Birmingham Retirement & Relief System ... [Published FINalternatives - 22 hours ago]

Entities: SAC Capital Advisors LP, Plaintiff, Élan Corporation plc, Lawsuit, Appointed

First reported Jun 18 2013 - Updated Jun 18 2013 - 2 reports

Theravance Inc

Seth Klarman’s Baupost Takes Profit On Stake In Elan Corp

As Elan Corporation, plc (NYSE:ELN) and private investment firm Royalty Pharma were sparring over who got to buy Elan, Seth Klarman’s Baupost Group decided to take some profits on its investment in the biotechnology company. According to regulatory filings ... [Published Value Walk - Jun 18 2013]

Entities: Élan Corporation plc, Seth Klarman, Royalty Pharma Management LLC, Theravance Inc

First reported Jun 18 2013 - Updated Jun 18 2013 - 5 reports

Élan Corporation plc

Royalty Pharma Announces Withdrawal of Judicial Review and Lapse of Offer

Royalty Pharma announced today that it had withdrawn its request for a judicial review of the Irish Takeover Panel's decision requiring it to lapse its offer for Elan Corporation, plc if, among other things, Elan shareholders approved the Share Repurchase ... [Published Big News Network - Jun 18 2013]

Entities: Royalty Pharma Management LLC, Élan Corporation plc, Stock Buyback

First reported Jun 18 2013 - Updated Jun 18 2013 - 2 reports

New York Stock Exchange

Elan Corp (ELN) Could Be Worth $19 in a Takeout - Jefferies

Jefferies boosted its price target dramatically on takeover target Elan Corp (NYSE: ELN) from $14 to $19, while reiterating their Buy rating. The firm seeks to answer the 4 main questions on the minds of investors: (1) Who is going to buy ELN? (2) What ... [Published Street Insider - Jun 18 2013]

Entities: Élan Corporation plc, New York Stock Exchange, Corey Davis, Taxes, Regeneron

First reported Jun 17 2013 - Updated Jun 18 2013 - 3 reports

Elan Advises Shareholders To Withdraw Acceptances Of Royalty Pharma Offer

Elan Corp. Plc (ELN: Quote) Tuesday advised its shareholders to withdraw any acceptances of Royalty Pharma's offer without delay and not to tender any further acceptances.Following the outcome of the Elan EGM yesterday, and in accordance with the terms ... [Published RTTNews.com - Jun 18 2013]

Entities: Royalty Pharma Management LLC, Élan Corporation plc

First reported Jun 17 2013 - Updated Jun 18 2013 - 12 reports

Royalty bid for Elan now hinges on court action

Royalty's multi-billion dollar bid was conditional upon shareholders at the Dublin-based firm rejecting four resolutions put forward by Elan bosses at its EGM in Dublin yesterday. Desperate to stay in the fight, Royalty last week won an Irish court injunction ... [Published Irish Independent - Jun 18 2013]

Entities: Élan Corporation plc, Royalty Pharma Management LLC, Tysabri, Injunction, Hostile

First reported Jun 17 2013 - Updated Jun 17 2013 - 2 reports

Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now

DUBLIN (TheStreet) -- Elan's (ELN)Royalty is offering $12.50 per share for Elan plus another $2.50 per share contingent on the multiple sclerosis drug Tysabri hitting certain sales targets. However, Royalty's tender offer was forced to lapse because Elan ... [Published TheStreet.com - Jun 17 2013]

Entities: Élan Corporation plc, Royalty Pharma Management LLC, Takeover, Tender Offer

First reported Jun 17 2013 - Updated Jun 17 2013 - 10 reports

Elan shareholders approve one of four transactions

Elan shareholders approved one of four transactions up for a vote at its special meeting Monday. Shareholders rejected plans for a $1 billion cash acquisition of a 21% stake in Theravance’s royalties from the respiratory franchise it shares with GSK; ... [Published Center Watch - Jun 17 2013]

Entities: Élan Corporation plc, Royalty Pharma Management LLC, Takeover Panel, Stock Buyback

First reported Jun 17 2013 - Updated Jun 17 2013 - 8 reports

Investors snub Elan deals, but buyback win could scuttle hostile offer

Elan's ($ELN) shareholders rejected a string of CEO Kelly Martin's deals today but did green-light a share repurchase pact--which the biotech says will put the hex on Royalty Pharma's hostile $8 billion offer for the company. The hostile bid, though, ... [Published FierceBiotech - Jun 17 2013]

Entities: Élan Corporation plc, Hostile, Kelly Martin

Quotes

...service, who has now resigned, this time the issues are more fundamental than those in the winter protests, the Bulgarian daily Sega observes: "The people taking part in these protests are different in that they have the necessary experience to provoke major social change. An MP once said that the nation's elite was sitting in parliament. Today this is no longer true, because the nation's elite is now on the streets. It is calling for new election laws, media freedom, new rules for the distribution of public funds and a functioning justice system. The elite is disgusted and this is why it must intervene in politics. Because politics is not a dirty business. It is the people who have turned it into such a thing that are dirty."

Wednesday Newspaper Review - Irish Business News and International Stories - - June 19, 2013 [Published FinFacts - 5 hours ago]

...to shortlist of seven names: Allergan, Regeneron, Vertex, Alexion, Mylan, Perrigo and, less obviously, Pfizer's animal health spin-off Zoetis. "We are sure there are more and this is not an exhaustive list, but we think it's a start" he concludes

Royalty pulls out so who will buy Elan? [Published Pharma Times - 8 hours ago]

"We believe Elan's shareholders should view your announcement of a sale process, and the likelihood that any such sale process will yield a better offer than Royalty Pharma's, with some scepticism."

Royalty drops hostile bid to buy Elan [Published Irish Independent - 10 hours ago]

"The Elan Board and management are aligned in maximising the full value potential of the business on behalf of its shareholders" the company said in a June 14 statement

Royalty gives up bid for Elan [Published NineMSN Finance - 17 hours ago]

More Content

sort by: Date \| Relevance
UPDATE 1: Wednesday's movers: Sprint down as Di... [Published TD Ameritrade - 53 mins ago]
4 Merger and Acquisitions Stock Stories Making ... [Published Wall St. Cheat Sheet - 2 hours ago]
4 Merger and Acquisitions Stock Stories Making ... [Published Wall St. Cheat Sheet - 2 hours ago]
Wednesday Newspaper Review - Irish Business New... [Published FinFacts - 5 hours ago]
Royalty pulls out so who will buy Elan? [Published Pharma Times - 8 hours ago]
Royalty pulls out so who will buy Elan [Published Big News Network - 8 hours ago]
Royalty drops hostile bid to buy Elan [Published Irish Independent - 10 hours ago]
Words not figures proved the undoing of Royalty... [Published Irish Times - 14 hours ago]
GE Forms JV In Russia For Mini Power Plants and... [Published Wall St. Cheat Sheet - 16 hours ago]
GE Forms JV In Russia For Mini Power Plants and... [Published Wall St. Cheat Sheet - 16 hours ago]
Royalty gives up bid for Elan [Published NineMSN Finance - 17 hours ago]
Is Elan Corporation, plc (ADR) (ELN) Pushing It... [Published InsiderMonkey.com - 18 hours ago]
Is Elan Pushing Its Luck? [Published Motley Fool - 19 hours ago]
Royalty gives up bid for Irish biotech firm Elan [Published TheJournal.ie - 19 hours ago]
Biogen Idec Inc. (BIIB): Elan Corporation, plc ... [Published InsiderMonkey.com - 19 hours ago]
Royalty Pharma drops bid for Elan Corp. [Published Drug Store News - 21 hours ago]
Royalty drops hostile bid for Ireland’s Elan [Published Globe and Mail - 21 hours ago]
Royalty drops hostile bid for Elan [Published RTE Online - 21 hours ago]
Pension Appointed Lead Plaintiff In Lawsuit Aga... [Published FINalternatives - 22 hours ago]
Royalty Pharma Is Not Buying Elan Corporation [Published Value Walk - 22 hours ago]
Seth Klarman’s Baupost Takes Profit On Stake In... [Published Value Walk - Jun 18 2013]
Form 8.3 -Elan Corporation plc [Published MoneyAM - Jun 18 2013]
UPDATE 1-Royalty drops hostile bid for Ireland'... [Published CNBC - Jun 18 2013]
Royalty Pharma Drops Hostile Bid for Elan Corpo... [Published BioSpace - Jun 18 2013]
Klarman's Baupost Sells 2M Shares of Elan (ELN) [Published Street Insider - Jun 18 2013]
Royalty Pharma Announces Withdrawal of Judicial... [Published Big News Network - Jun 18 2013]
Form 8.3 - [ELAN CORPORATION PLC] [Published MoneyAM - Jun 18 2013]
Royalty Pharma lets Elan takeover bid expire [Published Beaumont Enterprise - Jun 18 2013]
Royalty Pharma Announces Withdrawal of Judicial... [Published PharmaceuticalProcessing - Jun 18 2013]
Royalty drops hostile bid for Ireland's Elan [Published 4 Traders - Jun 18 2013]

Blogs

sort by: Date \| Relevance
4 Merger and Acquisitions Stock Stories Making ... [Published Wall St. Cheat Sheet - 2 hours ago] Nokia Corporation ( NYSE : NOK ): Current price $ 3.86The German industrial conglomerate Siemens is looking for offers from private equity companies to purchase its interest in its telecoms equipment joint venture Nokia Siemens Networks, according to ...
4 Merger and Acquisitions Stock Stories Making ... [Published Wall St. Cheat Sheet - 2 hours ago] Nokia Corporation ( NYSE:NOK ): Current price $3.86 The German industrial conglomerate Siemens is looking for offers from private equity companies to purchase its interest in its telecoms equipment joint venture Nokia Siemens Networks, according ...
GE Forms JV In Russia For Mini Power Plants and... [Published Wall St. Cheat Sheet - 16 hours ago] General Electric Company ( NYSE : GE ): Current price $ 24.33On Tuesday, it was announced that GE will create a joint venture with Russia’s state-funded private equity vehicle Russian Direct Investment Fund, through which to build mini power plants across Russia. For ...
GE Forms JV In Russia For Mini Power Plants and... [Published Wall St. Cheat Sheet - 16 hours ago] General Electric Company ( NYSE:GE ): Current price $24.33 On Tuesday, it was announced that GE will create a joint venture with Russia’s state-funded private equity vehicle Russian Direct Investment Fund, through which to build mini power plants ...
Supreme Court Rules in ANDROGEL Patent Settleme... [Published FDA Law Blog - Jun 17 2013] By Kurt R. Karst –On June 17th, the U.S. Supreme Court issued its much-anticipated opinion in Federal Trade Commission v. Actavis, Inc., 570 U.S. ___ (2013) (Docket No. 12-416) concerning drug patent settlement agreements (aka “reverse payment agreements” ...

Audio/Video

sort by: Date \| Relevance
Dollar Strength Hits Oil, Gold [Published TheStreet.com - YouTube - May 13 2013]

Press Releases

sort by: Date \| Relevance
Royalty Pharma Announces Withdrawal Of Judicial... [Published Financial Services - Jun 18 2013]
Elan Advises Shareholders to Withdraw Any Accep... [Published Business Wire Health News - Jun 18 2013]
The BauPost Group: Rule 8.3 Filing – Elan Corpo... [Published EON Business - Jun 18 2013]
The BauPost Group: Rule 8.3 Filing – Elan Corpo... [Published Business Wire Professional Services News - Jun 18 2013]
Royalty Pharma Informs Elan Stockholders About ... [Published Financial Services - Jun 17 2013]